AAAAAA

   
Results: 1-20 |
Results: 20
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer
Authors: Bass, SS Cox, CE Salud, CJ Lyman, GH McCann, C Dupont, E Berman, C Reintgen, DS
Citation: Ss. Bass et al., The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer, J AM COLL S, 192(1), 2001, pp. 9-16
Hematopoietic growth factors in the older cancer patient
Authors: Balducci, L Hardy, CL Lyman, GH
Citation: L. Balducci et al., Hematopoietic growth factors in the older cancer patient, CURR OPIN H, 8(3), 2001, pp. 170-187
Evaluation and appraisal of randomized controlled trials in myeloma
Authors: Djulbegovic, B Adams, JR Lyman, GH Lacevic, M Hozo, I Greenwich, M Bennett, CL
Citation: B. Djulbegovic et al., Evaluation and appraisal of randomized controlled trials in myeloma, ANN ONCOL, 12(11), 2001, pp. 1611-1617
Patients aged <= 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy
Authors: Balducci, L Lyman, GH
Citation: L. Balducci et Gh. Lyman, Patients aged <= 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy, J CL ONCOL, 19(5), 2001, pp. 1583-1584
Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system
Authors: Balch, CM Soong, SJ Gershenwald, JE Thompson, JF Reintgen, DS Cascinelli, N Urist, M McMasters, KM Ross, MI Kirkwood, JM Atkins, MB Thompson, JA Coit, DG Byrd, D Desmond, R Zhang, YT Liu, PY Lyman, GH Morabito, A
Citation: Cm. Balch et al., Prognostic factors analysis of 17,600 melanoma patients: Validation of theAmerican Joint Committee on Cancer melanoma staging system, J CL ONCOL, 19(16), 2001, pp. 3622-3634
Economic analysis of cancer clinical trials
Authors: Lyman, GH
Citation: Gh. Lyman, Economic analysis of cancer clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 291-320
Evidentiary challenges to evidence-based medicine
Authors: Djulbegovic, B Morris, L Lyman, GH
Citation: B. Djulbegovic et al., Evidentiary challenges to evidence-based medicine, J EVAL CL P, 6(2), 2000, pp. 99-109
A novel approach to maintain planned dose chemotherapy on time: a decision-making tool to improve patient care
Authors: Lyman, GH
Citation: Gh. Lyman, A novel approach to maintain planned dose chemotherapy on time: a decision-making tool to improve patient care, EUR J CANC, 36, 2000, pp. S15-S21
Quality of life after coronary angioplasty or continued medical treatment for angina: Three-year follow-up in the RITA-2 trial
Authors: Pocock, SJ Henderson, RA Clayton, T Lyman, GH Chamberlain, DA
Citation: Sj. Pocock et al., Quality of life after coronary angioplasty or continued medical treatment for angina: Three-year follow-up in the RITA-2 trial, J AM COL C, 35(4), 2000, pp. 907-914
What threshold for adjuvant therapy in older breast cancer patients?
Authors: Extermann, M Balducci, L Lyman, GH
Citation: M. Extermann et al., What threshold for adjuvant therapy in older breast cancer patients?, J CL ONCOL, 18(8), 2000, pp. 1709-1717
A predictive model for neutropenia associated with cancer chemotherapy
Authors: Lyman, GH
Citation: Gh. Lyman, A predictive model for neutropenia associated with cancer chemotherapy, PHARMACOTHE, 20(7), 2000, pp. 104S-111S
Quality of life after adjuvant chemotherapy for breast cancer
Authors: Broeckel, JA Jacobsen, PB Balducci, L Horton, J Lyman, GH
Citation: Ja. Broeckel et al., Quality of life after adjuvant chemotherapy for breast cancer, BREAST CANC, 62(2), 2000, pp. 141-150
Industry-sponsored research - Reply
Authors: Djulbegovic, B Bennett, CL Adams, JR Lyman, GH
Citation: B. Djulbegovic et al., Industry-sponsored research - Reply, LANCET, 356(9248), 2000, pp. 2194-2194
The uncertainty principle and industry-sponsored research
Authors: Djulbegovic, B Lacevic, M Cantor, A Fields, KK Bennett, CL Adams, JR Kuderer, NM Lyman, GH
Citation: B. Djulbegovic et al., The uncertainty principle and industry-sponsored research, LANCET, 356(9230), 2000, pp. 635-638
Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer
Authors: Cox, CE Bass, SS McCann, CR Ku, NNK Berman, C Durand, K Bolano, M Wang, J Peltz, E Cox, S Salud, C Reintgen, DS Lyman, GH
Citation: Ce. Cox et al., Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer, ANN R MED, 51, 2000, pp. 525-542
Talking about treatment
Authors: Djulbegovic, B Lyman, GH Hozo, I
Citation: B. Djulbegovic et al., Talking about treatment, ANN INT MED, 132(1), 2000, pp. 94-94
The effects of NSAIDs on breast cancer prognostic factors
Authors: Schapira, DV Theodossiou, C Lyman, GH
Citation: Dv. Schapira et al., The effects of NSAIDs on breast cancer prognostic factors, ONCOL REP, 6(2), 1999, pp. 433-435
Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates
Authors: Jacobsen, PB Hann, DM Azzarello, LM Horton, J Balducci, L Lyman, GH
Citation: Pb. Jacobsen et al., Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates, J PAIN SYMP, 18(4), 1999, pp. 233-242
The economics of febrile neutropenia: Implications for the use of colony-stimulating factors
Authors: Lyman, GH Kuderer, N Greene, J Balducci, L
Citation: Gh. Lyman et al., The economics of febrile neutropenia: Implications for the use of colony-stimulating factors, EUR J CANC, 34(12), 1998, pp. 1857-1864
Methodological challenges in the evaluation of prognostic factors in breast cancer
Authors: Altman, DG Lyman, GH
Citation: Dg. Altman et Gh. Lyman, Methodological challenges in the evaluation of prognostic factors in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 289-303
Risultati: 1-20 |